Cidara Therapeutics Stock Forecast - Relative Strength Index
| CDTX Stock | USD 221.38 0.06 0.03% |
Cidara Stock outlook is based on your current time horizon.
The RSI of Cidara Therapeutics' share price is above 70 at this time suggesting that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Cidara, making its price go up or down. Momentum 76
Buy Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (1.49) | EPS Estimate Current Year (8.68) | EPS Estimate Next Year (7.21) | Wall Street Target Price 221.5 | EPS Estimate Current Quarter (1.33) |
Using Cidara Therapeutics hype-based prediction, you can estimate the value of Cidara Therapeutics from the perspective of Cidara Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cidara Therapeutics using Cidara Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cidara using crowd psychology based on the activity and movement of Cidara Therapeutics' stock price.
Cidara Therapeutics Short Interest
An investor who is long Cidara Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Cidara Therapeutics and may potentially protect profits, hedge Cidara Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 89.0494 | Short Percent 0.0643 | Short Ratio 1.34 | Shares Short Prior Month 2.1 M | 50 Day MA 196.9386 |
Cidara Relative Strength Index
Cidara Therapeutics Hype to Price Pattern
Investor biases related to Cidara Therapeutics' public news can be used to forecast risks associated with an investment in Cidara. The trend in average sentiment can be used to explain how an investor holding Cidara can time the market purely based on public headlines and social activities around Cidara Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Cidara Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Cidara Therapeutics.
Cidara Therapeutics Implied Volatility | 0.86 |
Cidara Therapeutics' implied volatility exposes the market's sentiment of Cidara Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cidara Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cidara Therapeutics stock will not fluctuate a lot when Cidara Therapeutics' options are near their expiration.
Cidara Therapeutics after-hype prediction price | USD 221.52 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. Prediction based on Rule 16 of the current Cidara contract
Based on the Rule 16, the options market is currently suggesting that Cidara Therapeutics will have an average daily up or down price movement of about 0.0538% per day over the life of the 2026-02-20 option contract. With Cidara Therapeutics trading at USD 221.38, that is roughly USD 0.12 . If you think that the market is fully incorporating Cidara Therapeutics' daily price movement you should consider acquiring Cidara Therapeutics options at the current volatility level of 0.86%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-02-20 Cidara Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Cidara Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Cidara Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Cidara Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Cidara Therapeutics' open interest, investors have to compare it to Cidara Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Cidara Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Cidara. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Cidara Therapeutics Additional Predictive Modules
Most predictive techniques to examine Cidara price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cidara using various technical indicators. When you analyze Cidara charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 76.58 | 76.58 |
| Check Cidara Therapeutics Volatility | Backtest Cidara Therapeutics | Information Ratio |
Cidara Therapeutics Trading Date Momentum
| On January 27 2026 Cidara Therapeutics was traded for 221.38 at the closing time. The top price for the day was 221.41 and the lowest listed price was 221.25 . There was no trading activity during the period 0.0. Lack of trading volume on January 27, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.03% . |
Cidara Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cidara Therapeutics stock to make a market-neutral strategy. Peer analysis of Cidara Therapeutics could also be used in its relative valuation, which is a method of valuing Cidara Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cidara Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Cidara Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cidara Therapeutics shares will generate the highest return on investment. By undertsting and applying Cidara Therapeutics stock market strength indicators, traders can identify Cidara Therapeutics entry and exit signals to maximize returns.
Cidara Therapeutics Risk Indicators
The analysis of Cidara Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cidara Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cidara stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.25 | |||
| Semi Deviation | 1.3 | |||
| Standard Deviation | 13.28 | |||
| Variance | 176.3 | |||
| Downside Variance | 6.8 | |||
| Semi Variance | 1.7 | |||
| Expected Short fall | (4.61) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cidara Therapeutics
The number of cover stories for Cidara Therapeutics depends on current market conditions and Cidara Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cidara Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cidara Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Cidara Therapeutics Short Properties
Cidara Therapeutics' future price predictability will typically decrease when Cidara Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cidara Therapeutics often depends not only on the future outlook of the potential Cidara Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cidara Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.3 M | |
| Cash And Short Term Investments | 189.8 M |
Additional Tools for Cidara Stock Analysis
When running Cidara Therapeutics' price analysis, check to measure Cidara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cidara Therapeutics is operating at the current time. Most of Cidara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cidara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cidara Therapeutics' price. Additionally, you may evaluate how the addition of Cidara Therapeutics to your portfolios can decrease your overall portfolio volatility.